摘要
目的:评价中重度慢性阻塞性肺疾病(COPD)缓解期患者自我管理的效果,达到减少急性发作次数、提高生活质量的目的。方法:将110例中重度COPD缓解期患者随机分成两组,对照组60例予常规西药治疗,观察组50例在对照组治疗基础上加用自我管理。观察两组COPD急性发作次数、住院次数、医疗费用、症状控制时间、肺功能和CAT评分等变化情况。结果:观察组的COPD急性发作次数、住院次数、医疗费用、CAT评分每天分数均值均明显少于对照组(P<0.05);对照组治疗后FEV_1和FEV_1/FVC较治疗前明显降低(P<0.05),其中FEV_1/FVC降低更明显,与观察组治疗后比较差异有统计学意义(P<0.05)。结论:自我管理能明显减少中重度COPD缓解期患者急性发作次数、住院次数、医疗费用,改善患者肺功能和提高患者生活质量。
Objective:To evaluate the efficacy of self-management in the patient of catabatic period with moderate-severe chronic obstructive pulmonary disease (COPD) and in order to decrease the times of acute attack and raise the life quality.Method:The 110 moderate-severe COPD patients of catabatic period were divided into two groups at random.The control group was 60 cases and was treated by routine treatment with Western medicine. The observation group was 50 cases and plus self-management on the basis of control group.The alterations of acute attack times,hospitalized times,medical costs, symptom control time,lung function and CAT score were observed in two groups.Result:The average value of acute attack times,hospitalized times,medical costs, symptom control time,lung function and CAT score for the observation group apparently was low to the control group(P〈0.05).The FEV1 and FEV1/FVC after treatment were obviously decrease in contrast to before treatment for control group (P〈0.05).The decrease of FEV1/FVC was more obvious for the control group after treatment and had the statistical significance in contrast with the observation group(P〈0.05).Conclusion:The self-management can evidently reduce the acute attack times,hospitalized times,medical costs and improve lung function and raise quality of life for moderate-severe COPD patients of catabatic period.
出处
《中国医学创新》
CAS
2016年第20期125-128,共4页
Medical Innovation of China
基金
2013年度江门市卫生系统医学科研立项项目(13A028)
关键词
中重度慢性阻塞性肺疾病
缓解期
自我管理
临床效果
Moderate-severe chronic obstructive pulmonary disease
Catabatic period
Self-management
Clinical effect